The effect of naftidrofuryl on intermittent claudication: A meta-analysis

Journal of Cardiovascular Pharmacology

Volumn 16, Issue , 1990, Pages S81-S86

  Lehert, P ^a   Riphagen, F E ^a   Gamand, S ^b  

^a Department of Computer Science and Statistics ^*  (Belgium)

^b LIPHA Industries   (France)

Author keywords

Automatic interaction detection; Meta analysis; Naftidrofuryl; Peripheral arterial disease

Indexed keywords

NAFTIDROFURYL;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; WALKING;

ADULT; AGED; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMAN; INTERMITTENT CLAUDICATION; MULTICENTER STUDIES; NAFRONYL;

EID: 0025688822     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199000163-00019     Document Type: Article

References (15)

1. Becker HM, Eiert O, Haring R, et al. Wirksamkeitsnachweis von Dusodril Pi bei peripherer Verschlusskrankheit. Med Welt 1979;30:1602-1606.
2. Clyne CAC, Galland RB, Fox MJ, et al. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication. Br J Surg 1980:67:347-348.
3. Karnik R. et al. Effects of naftidrofuryl in patients with intermittent claudication. Angiology 1988;39:234-240.
4. Pohle W. Hirche H, Barmeyer J. et al. Doppelblindstudie mit Naftidrofuryl-Hydrogenoxalat bei patienten mit peripherer arteriellen Verschlusskrankheit. Med Welt 1979:30:269-272.
5. Adhoute G, Bacourt F. Barrai M, et al. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study. Using Naftidrofuryl tablets 200 mg. Angiology 1986:37:160-167.
6. Adhoute G. Andreassian B, Boccalon H. et al. Treatment of stage 11 chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: Results after 6 months of a controlled multicenter study. J Cardiovasc Pharmacol 1990;16(SUPPL. 3):75-80 (this issue).
7. Trubestein G, et al. Naftidrofuryl bei arterieller Verschlusskrankheit. Dtsch Med Wochenschr 1984;109:745-750.
8. Kriessmann A, Neiss A. Klinischer Wirksamkeitsnachweis von Naftidrofuryl bei Claudicatio intermittens. Vasa 1988;17(SUPPL. 24):27-32.
9. Rosenthal R. Combining results of independant studies. Psychol Bull 1978:85:185-193.
10. Snedecor GW. Cochran WG. Statistical methods, 6th edition. Ames: Iowa State University Press, 1967.
11. Cochran WG, Cox GM. Experimental designs. 2nd edition. New York: Wiley, 1957 (1st corrected printing 1968).
12. Greenhouse SW, Geisser S. On methods in analysis of profile data. Psychometrica 1959:24:95-112.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
14. Morgan JN, Sonquist JA. Problems in the analysis of survey data and a proposal. J Am Stat Soc 1963;58:415-434.
15. Johnston KW, et al. An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease. Ann Vase Surg 1988:2(2):101-107.